Latest papers

A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins.

Apocrine carcinoma of the breast.

What's Wrong With Chemoprevention of Prostate Cancer?

Good ethics begins with sound medicine: prostate cancer screening and chemoprevention.

[Quiscent trophoblastic disease].

Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer.

Prostate Cancer Prevention: Do the 5-ARIs Make the Grade?

A rational basis for chemoprevention of prostate cancer.

Non-coding RNAs in cancer initiation and progression and as novel biomarkers

Forfeited health: response to open peer commentaries on "What's wrong with chemoprevention of prostate cancer?".

Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.

Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.

Prognosis.

[Metastatic dermatofibrosarcoma: an unusual cause of mediastinal mass].

Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.

Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method.

Abstracts of ISOBM 2011, the 39th Meeting of the International Society of Oncology and BioMarkers. October 15 - 19, 2011. Florence, Italy.

Tightly-bound to DNA proteins in rat experimental hepatomas and normal liver cells.

A review of excision repair cross-complementation group 1 in colorectal cancer.

Characteristics and management of adnexal masses in a canadian pediatric and adolescent population.